TMS Therapy for Off-Label Conditions in Scottsdale, AZ
At The Schulte Institute in Scottsdale, AZ, we offer Transcranial Magnetic Stimulation (TMS) as an advanced, non-invasive treatment option not only for its FDA-cleared indications — Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD) — but also for several additional conditions where growing clinical research and physician experience have demonstrated promising results. Off-label TMS use means the treatment is applied to a condition not yet carrying FDA approval for that specific indication, but supported by peer-reviewed studies and expert clinical judgment. Each patient is carefully evaluated by Dr. Schulte or Dr. Koreny to determine whether off-label TMS is an appropriate option for their individual needs.
Request an AppointmentTMS for Anxiety (Off-Label)
Generalized Anxiety Disorder (GAD) is characterized by persistent, excessive worry lasting longer than six months, along with symptoms that can include panic attacks, restlessness, irritability, fatigue, sleep disturbances, and changes in appetite. These symptoms can significantly impair daily functioning, relationships, and overall quality of life — and for many patients, traditional treatments do not provide adequate or lasting relief.
Standard treatment for GAD often includes medications such as benzodiazepines and antidepressants. While effective for some, long-term use of these medications may carry risks including cognitive side effects, dependency concerns, and interactions with other substances. TMS offers a non-medication alternative that targets the brain regions involved in mood and anxiety regulation. Providers at The Schulte Institute use right-sided TMS protocols for anxiety with encouraging clinical results, typically applying lower-frequency stimulation that is well tolerated and associated with minimal side effects. Treatment typically involves 20 to 30 sessions, with many patients experiencing meaningful improvements in anxiety symptoms. Supporting research is available at the National Institutes of Health: TMS and Anxiety Research.
Please note that off-label TMS for anxiety is generally not covered by insurance. To explore FDA-cleared TMS options, visit our NeuroStar Advanced TMS Therapy page.
TMS for Cognitive Impairment and Dementia (Off-Label)
TMS is also an area of growing interest as a potential supportive therapy for cognitive impairment, including Mild Cognitive Impairment (MCI), Alzheimer’s disease, and related dementias. A recent review conducted by psychiatrists affiliated with Mayo Clinic and Harvard University analyzed multiple studies evaluating TMS in patients with cognitive decline. The findings suggest that TMS may support improvements in cognitive function and is generally well tolerated, with minimal adverse effects across the patient population studied.
In clinical settings, TMS has shown potential not only for the cognitive symptoms of dementia but also for associated conditions — such as anxiety and depression — which commonly co-occur in patients experiencing cognitive decline. While individual outcomes can vary and this use remains off-label, these findings highlight the growing potential for TMS as a supportive therapy for cognitive health. Supporting research is available here: TMS and Dementia Research. If you or a loved one is dealing with depression alongside cognitive changes, we also encourage you to review our Spravato (esketamine) page as an additional treatment option to consider.
TMS for Bipolar Depression (Off-Label)
Bipolar depression presents a particularly challenging treatment landscape. Many patients do not respond adequately to traditional mood stabilizers or antidepressants, and the risk of triggering a manic episode with certain medications adds an additional layer of complexity. While newer medications such as Vraylar and Caplyta have helped some patients, a significant number continue to experience persistent depressive episodes that impair their quality of life.
TMS is emerging as a promising additional option for carefully selected patients with bipolar depression. Research led by Dr. Scott Aaronson has demonstrated encouraging results, with a low risk of triggering manic symptoms when treatment is properly monitored and protocols are appropriately designed. This non-invasive approach offers patients with bipolar depression an option that does not rely on additional systemic medication. Supporting research is available here: TMS and Bipolar Depression Research. As with all off-label applications at The Schulte Institute, a comprehensive clinical evaluation is required before treatment is initiated. To learn more about how TMS works at the neurological level, visit our How It Works page.
Important Considerations for Off-Label TMS
Off-label TMS at The Schulte Institute is offered thoughtfully and transparently. All off-label applications are considered investigational from an insurance perspective, meaning they are generally not covered by insurance, and patients should expect to pay out of pocket for off-label TMS protocols. Treatment protocols are fully customized based on each patient’s clinical presentation, diagnosis, and goals, and a comprehensive evaluation by Dr. Schulte or Dr. Koreny is required before any off-label treatment begins. Patients with certain implanted medical devices or other contraindications may not be eligible for TMS in any form. All contraindications and safety considerations will be reviewed in full during your consultation. Call (480) 941-9004 or visit our appointments page to schedule your evaluation today.
Frequently Asked Questions: Off-Label TMS Therapy in Scottsdale
What does “off-label” TMS mean?
Off-label TMS means the treatment is being applied to a condition that has not yet received FDA approval for that specific indication. It does not mean the treatment is experimental or unsafe — off-label use of established treatments is common in medicine and is often supported by peer-reviewed clinical research. At The Schulte Institute, all off-label TMS protocols are grounded in published clinical evidence and require a thorough evaluation by Dr. Schulte or Dr. Koreny before treatment is initiated.
Is TMS for anxiety effective?
Clinical research and physician experience support the use of TMS for Generalized Anxiety Disorder (GAD), particularly right-sided, lower-frequency TMS protocols. Many patients experience meaningful improvements in anxiety symptoms over a course of 20 to 30 sessions. While TMS for anxiety is not FDA-approved, it offers a non-medication alternative for patients who have not found adequate relief from traditional pharmacological treatments. Supporting research is available from the National Institutes of Health.
Is off-label TMS covered by insurance?
Generally, no. Off-label TMS is typically not covered by insurance, as coverage is reserved for FDA-cleared indications such as MDD and OCD. Patients seeking off-label TMS at The Schulte Institute should expect to pay out of pocket for treatment. If you are interested in FDA-cleared TMS therapy and insurance coverage, visit our Insurance Coverage page and our NeuroStar Advanced TMS Therapy page.
Can TMS help with cognitive decline or dementia symptoms?
Emerging research suggests that TMS may offer supportive benefits for patients with Mild Cognitive Impairment (MCI), Alzheimer’s disease, and related dementias — including improvements in cognitive function and associated conditions like anxiety and depression. A review by psychiatrists affiliated with Mayo Clinic and Harvard found that TMS was generally well tolerated with minimal adverse effects in this population. This application remains off-label and outcomes vary by individual. A comprehensive evaluation at The Schulte Institute is required before pursuing this approach.
Is TMS safe for patients with bipolar disorder?
For carefully selected patients with bipolar depression, TMS can be administered safely with a low risk of triggering manic symptoms when properly monitored by experienced providers. Research by Dr. Scott Aaronson supports TMS as a viable option for bipolar depression in appropriate candidates. At The Schulte Institute, Dr. Schulte and Dr. Koreny conduct a thorough evaluation before recommending off-label TMS for any patient with bipolar disorder to ensure the protocol is designed appropriately for their clinical profile.
How do off-label TMS sessions differ from standard TMS sessions?
The core technology is the same — NeuroStar Advanced TMS — but the coil placement, stimulation frequency, and number of sessions may differ based on the specific condition being treated. For example, anxiety protocols typically use right-sided, lower-frequency stimulation rather than the left-sided, higher-frequency protocol used for depression. Treatment plans are fully individualized at The Schulte Institute and are designed by Dr. Schulte or Dr. Koreny based on your specific diagnosis, symptoms, and clinical history.
How do I find out if off-label TMS is right for me?
Schedule a consultation at The Schulte Institute by calling (480) 941-9004 or submitting a request through our appointments page. During your appointment, Dr. Schulte or Dr. Koreny will review your diagnosis, symptom history, current treatments, and medical background to determine whether off-label TMS is a clinically appropriate and safe option for your specific condition and goals.
